KLAUS R DR VEITINGER
CIK 1283972 · last filed 2025-10-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
66
Lifetime Open-Market Net
-$8.37M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| scPharmaceuticals Inc. (SCPH) Delisted | Director | — | $5.67 | — | $0 | 9 | 2025-10-07 |
| Tricida, Inc. (TCDA) Delisted | Director | 79,028 | $0.11 | $8.5K | -$4.64M | 19 | 2022-06-16 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 2,816 | $19.00 | $53.5K | -$1.78M | 26 | 2015-11-27 |
| Relypsa Inc (RLYP) Delisted | Director | 2,712 | — | — | -$1.96M | 12 | 2015-05-13 |
Recent Filings · Page 3 of 7
66 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-28 | Tricida, Inc. (TCDA) Delisted | Mixed | −8,000 | -$282.8K | EDGAR |
| 2019-02-27 | Tricida, Inc. (TCDA) Delisted | Mixed | −8,000 | -$268.0K | EDGAR |
| 2019-01-30 | Tricida, Inc. (TCDA) Delisted | Mixed | −4,000 | -$120.3K | EDGAR |
| 2019-01-28 | Tricida, Inc. (TCDA) Delisted | Mixed | −4,000 | -$123.6K | EDGAR |
| 2018-12-31 | Tricida, Inc. (TCDA) Delisted | Mixed | −1,440 | -$57.0K | EDGAR |
| 2018-12-28 | Tricida, Inc. (TCDA) Delisted | Mixed | −6,560 | -$242.5K | EDGAR |
| 2018-07-02 | Tricida, Inc. (TCDA) Delisted | Grant (A) | +3,632 | $0 | EDGAR |
| 2018-06-21 | scPharmaceuticals Inc. (SCPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-11-27 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +650 | $0 | EDGAR |
| 2015-11-12 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Mixed | — | -$176.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.